2025 HCPCS Code J9317
Injection, sacituzumab govitecan-hziy, 2.5 mg
TAGS: sacituzumab| Short Description | Sacituzumab govitecan-hziy |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2021 |
| HCPCS Action Effective Date | January 01, 2021 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J9259 - Paclitaxel (american regent)
- J9260 - Inj methotrexate sodium 50mg
- J9261 - Nelarabine injection
- J9262 - Inj, omacetaxine mep, 0.01mg
- J9263 - Oxaliplatin
- J9264 - Paclitaxel protein bound
- J9265 - Paclitaxel injection
- J9266 - Pegaspargase injection
- J9267 - Paclitaxel injection
- J9268 - Pentostatin injection
- J9269 - Inj. tagraxofusp-erzs 10 mcg
- J9270 - Plicamycin (mithramycin) inj
- J9271 - Inj pembrolizumab
- J9272 - Inj, dostarlimab-gxly, 10 mg
- J9273 - Inj tisotu vedotin-tftv, 1mg
- J9274 - Inj, tebentafusp-tebn, 1 mcg
- J9280 - Mitomycin injection
- J9281 - Mitomycin instillation
- J9285 - Inj, olaratumab, 10 mg
- J9286 - Inj glofitamab gxbm, 2.5 mg